• 44 Organisations —
  • Cancer Vaccine Industry Q3 2022 - By Vector
1. Advaxis 2002
2. Agenus 1994
3. Amal Therapeutics 2012
4. Antigen Express 1994
5. BrightPath Biotherapeutics 2003
6. BrigthPath Biotherapeutics 2003
7. Calviri 2018
8. CimCure
9. Elicio Therapeutics 2011
10. EpiThany 2014
11. Epivax Oncology 2017
12. Flow Pharma 1999
13. Frame Therapeutics
14. Galena Biopharma 2003
15. Generex Biotechnology 1983
16. Immunocore 2008
17. IO Biotech 2014
18. ISA Pharmaceuticals 2004
19. Lytix Biopharma 2003
20. Midatech Pharma 2000
21. OncoPep 2010
22. Onco Therapy Science
23. Oryx Translational Medicine
24. Oxford Vacmedix 2012
25. Pepscan 1999
26. pHLIP 2014
27. Precision Biologics 2012
28. Prima Biomed 2001
29. Rhovac ApS 2008
30. SapVax 2016
31. Scancell 1996
32. SELLAS Life Sciences 2006
33. Sotio PPF Group 2010
34. Strike Pharma
35. Sumitomo Pharma Oncology
36. Takis Biotech
37. Targovax 2010
38. Treos Bio 2013
39. Ultimovacs 2011
40. Vaccitech 2016
41. Vaxeal Holding 2009
42. Vaxil Bio 2007
43. Vaxon Biotech 2004
44. Viracta Therapeutic 2007

«Cancer Vaccine Industry Q3 2022 - By Vector»

  • — organisation
  • — hubs and other organisation types

Industries

CAR-T, Peptides and Proteins, Viral Vectors
Covid-19
DNA, Peptides and Proteins, RNA
Deep diagnostics
FemTech
Healthcare
Healthcare, Public
Peptides and Proteins
PharmTech
Private
Reproductive Health & Contraception
Women Cancer Treatment
test_custom_domain_2
© 2026